JP2007532632A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532632A5
JP2007532632A5 JP2007507931A JP2007507931A JP2007532632A5 JP 2007532632 A5 JP2007532632 A5 JP 2007532632A5 JP 2007507931 A JP2007507931 A JP 2007507931A JP 2007507931 A JP2007507931 A JP 2007507931A JP 2007532632 A5 JP2007532632 A5 JP 2007532632A5
Authority
JP
Japan
Prior art keywords
fold
hsp
induction
vehicle
data analysis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007507931A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532632A (ja
JP4790704B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IN2005/000112 external-priority patent/WO2005097746A2/en
Publication of JP2007532632A publication Critical patent/JP2007532632A/ja
Publication of JP2007532632A5 publication Critical patent/JP2007532632A5/ja
Application granted granted Critical
Publication of JP4790704B2 publication Critical patent/JP4790704B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007507931A 2004-04-12 2005-04-11 Hsp70誘発因子としての2−プロペン−1−オン Expired - Fee Related JP4790704B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN178KO2004 2004-04-12
IN178/KOL/2004 2004-04-12
PCT/IN2005/000112 WO2005097746A2 (en) 2004-04-12 2005-04-11 2-propene-1-ones as hsp 70 inducers

Publications (3)

Publication Number Publication Date
JP2007532632A JP2007532632A (ja) 2007-11-15
JP2007532632A5 true JP2007532632A5 (enExample) 2010-12-24
JP4790704B2 JP4790704B2 (ja) 2011-10-12

Family

ID=34972223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007507931A Expired - Fee Related JP4790704B2 (ja) 2004-04-12 2005-04-11 Hsp70誘発因子としての2−プロペン−1−オン

Country Status (12)

Country Link
US (1) US20080207608A1 (enExample)
EP (1) EP1748987A2 (enExample)
JP (1) JP4790704B2 (enExample)
KR (1) KR100825492B1 (enExample)
CN (1) CN1964946A (enExample)
AU (1) AU2005232159B2 (enExample)
BR (1) BRPI0509799A (enExample)
CA (1) CA2562130C (enExample)
MX (1) MXPA06011770A (enExample)
RU (1) RU2341522C2 (enExample)
WO (1) WO2005097746A2 (enExample)
ZA (1) ZA200608077B (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7893060B2 (en) * 2007-06-12 2011-02-22 F. Hoffmann-La Roche Ag Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase
KR100989093B1 (ko) 2008-01-18 2010-10-25 한화제약주식회사 생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
KR101799429B1 (ko) * 2010-05-03 2017-11-21 에스케이바이오팜 주식회사 신경 세포 사멸 또는 신경 퇴화를 억제하기 위한 약학적 조성물
CN103929959A (zh) 2011-08-12 2014-07-16 萨克生物研究学院 神经保护性多酚类似物
WO2013025484A1 (en) * 2011-08-12 2013-02-21 Lapchak Paul A Polyphenol analogs to treat ischemia
CN104520274B (zh) * 2012-03-29 2016-08-24 先进癌症治疗有限责任公司 Pfkfb3抑制剂和用作抗癌治疗剂的方法
WO2014123203A1 (ja) * 2013-02-06 2014-08-14 京都薬品工業株式会社 糖尿病治療薬
MY191366A (en) 2013-03-13 2022-06-20 Forma Therapeutics Inc Novel compounds and compositions for inhibition of fasn
WO2015187934A1 (en) * 2014-06-06 2015-12-10 Cureveda, Llc Functionalized hetroaryl enones exhibiting nrf2 activation and their method of use
WO2016031775A1 (ja) * 2014-08-25 2016-03-03 国立大学法人神戸大学 植物の耐性向上剤
CN105237487B (zh) * 2015-10-19 2017-10-10 安徽中医药大学 含川芎嗪基查尔酮芳氧烷酸类化合物、制备方法及其应用
WO2017083979A1 (en) * 2015-11-20 2017-05-26 Lee Hoyun Quinolone chalcone compounds and uses thereof
CN105503745B (zh) * 2016-01-07 2018-10-19 首都师范大学 含4-氧代喹唑啉-2-基的查耳酮类似物及其制备方法和用途
CN108558763B (zh) * 2018-05-16 2021-08-24 辽宁大学 含吲唑的查尔酮类衍生物及其应用
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
US10793554B2 (en) 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone
CN111171018B (zh) * 2018-11-13 2022-08-16 沈阳化工研究院有限公司 一种查尔酮类化合物及其应用
CN109620827B (zh) * 2018-12-14 2021-01-19 中国医学科学院医药生物技术研究所 杂环丙烯酮类化合物作为抗菌剂的用途
CA3148310A1 (en) * 2019-09-13 2021-03-18 Jun Qi Kdm inhibitors and uses thereof
CN114105927B (zh) * 2020-08-31 2023-10-24 湖南超亟检测技术有限责任公司 一种苯并吡喃腈类荧光分子探针的构建及其体外诊断应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348945A (en) * 1990-04-06 1994-09-20 Wake Forest University Method of treatment with hsp70
US5739170A (en) * 1992-09-11 1998-04-14 The Regents Of The University Of California Inhibitors of metazoan parasite proteases
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
US6096711A (en) * 1998-02-25 2000-08-01 Sherman; Michael Hsp72 induction and applications
WO2000018390A1 (fr) * 1998-09-28 2000-04-06 Hsp Research Institute, Inc. Inducteurs d'expression de proteine de choc thermique
US6174875B1 (en) * 1999-04-01 2001-01-16 University Of Pittsburgh Benzoquinoid ansamycins for the treatment of cardiac arrest and stroke
AU2003229537A1 (en) * 2002-05-17 2003-12-02 Lica Pharmaceuticals A/S Amino-functional chalcones
EP1684762A4 (en) * 2003-11-13 2009-06-17 Ambit Biosciences Corp UREA DERIVATIVES AS MODULATORS OF KINASE

Similar Documents

Publication Publication Date Title
JP2007532632A5 (enExample)
JP2013500371A5 (enExample)
LTPA2017011I1 (lt) Antikūnas prieš PDGFR-alfa, skirtas naudoti auglių gydymui
NO345018B1 (no) Framgangsmåte for framstilling av organofluorforbindelser i alkoholholdige løsningsmidler.
JP2011121989A5 (enExample)
EP2803675A3 (en) Ferroportin antibodies and methods of use
JP2010538767A5 (enExample)
JP2010506699A5 (enExample)
IL236427A (en) Isolated amino acids, vectors, host cells, and antibody preparation methods il-23p19
JP2010514554A5 (enExample)
BRPI0922106A2 (pt) anticorpo monoclonal isolado, molécula de ácido nucleico isolada, célula hospedeira, método para produzir um anticorpo monoclonal isolado, composição farmacêutica, e, uso da composição
JP2010262436A5 (enExample)
JP2008208052A5 (enExample)
DE602006004507D1 (de) Härtbare Zusammensetzungen, die reaktive Beta-Hydroxylamide aus Lactonen enthalten
JP2010241791A5 (enExample)
JP2012518389A5 (enExample)
JP2010505386A5 (enExample)
DE602008006254D1 (de) Doppel-oligonukleotid-nukleinsäurenachweisverfahren
EP2366691A4 (en) NITROPYRIDINYLETHYLENIMINE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
UA107201C2 (uk) 4-[етил(диметил)амоній]бутаноат та його застосування в лікуванні серцево-судинної хвороби
JP2012001501A5 (enExample)
JP2013094739A5 (enExample)
JP2006275751A5 (enExample)
JP2005241299A5 (enExample)
JP2013189393A5 (enExample)